Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy

  • 1,
  • 1,
  • 1, 2,
  • 1,
  • 1, 2,
  • 1,
  • 1,
  • 1, 3,
  • 1, 4,
  • 4,
  • 5,
  • 6,
  • 1,
  • 4 and
  • 1Email author
Journal of Hematology & Oncology201811:90

https://doi.org/10.1186/s13045-018-0633-1

  • Received: 25 June 2018
  • Accepted: 25 June 2018
  • Published:

The original article was published in Journal of Hematology & Oncology 2018 11:58

Correction

The original article [1] contains a spelling error in the authorship; the authors would like to note the correct spelling of the second author, Jiajia Xi.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA
(2)
Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, 510631, China
(3)
Raman Fellow (UGC), Department of Biochemistry, University of Allahabad, Allahabad, India
(4)
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, 450000, Henan Province, China
(5)
Cancer Research Institute, Central South University, Changsha, 410078, China
(6)
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA

Reference

  1. Huang Q, et al. miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy. J Hematol Oncol. 2018;11:58.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement